Marinomed Starts Restructuring Proceedings As Debts Mount

Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.

• Source: Shutterstock

Austrian biotech Marinomed has filed for insolvency as revenue expectations for the 2024 financial year could not be realized as anticipated.

More from Strategy

More from Ingredients & Safety

UK Finds Turmeric Supplements Pose Risk To Health

 
• By 

UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.

CIR Panel: Hair Dye PPD ‘Unsafe’ For Skin, Brow, Lash Applications

 
• By 

The Expert Panel for Cosmetic Ingredient Safety issued a revised tentative amended report for p-phenylenediamine and related ingredients during its 171st meeting.

First UK CBD Novel Food Authorizations Expected In 2025

 
• By 

FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.